Cargando…
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens
BACKGROUND: At present, seroreactivity is not a valuable parameter for diagnosis of Human Papillomavirus (HPV) infection but, it is potentially valuable as marker of viral exposure in elucidating the natural history of this infection. More data are needed to asses the clinical relevance of serologic...
Autores principales: | Giorgi, Colomba, Di Bonito, Paola, Grasso, Felicia, Mochi, Stefania, Accardi, Luisa, Donà, Maria Gabriella, Branca, Margherita, Costa, Silvano, Mariani, Luciano, Agarossi, Alberto, Ciotti, Marco, Syrjänen, Kari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474580/ https://www.ncbi.nlm.nih.gov/pubmed/18582363 http://dx.doi.org/10.1186/1750-9378-3-9 |
Ejemplares similares
-
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
por: Di Bonito, Paola, et al.
Publicado: (2006) -
Characterization of antibodies in single-chain format against the E7 oncoprotein of the Human papillomavirus type 16 and their improvement by mutagenesis
por: Donà, Maria Gabriella, et al.
Publicado: (2007) -
Cervical Microbiome in Women Infected with HPV16 and High-Risk HPVs
por: Sasivimolrattana, Thanayod, et al.
Publicado: (2022) -
Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019) -
Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants
por: Ozbun, Michelle A., et al.
Publicado: (2021)